Catalyst Wire Dossier Catalyst Wire Dossier

CHILDRENS IBUPROFEN ORAL SUSPENSION

Ibuprofen · PAI Holdings, LLC dba PAI Pharma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHILDRENS IBUPROFEN ORAL SUSPENSION, covering 2024-11-08 to 2024-11-08. Get the full timeline:

Most recent: FDA Approved: CHILDRENS IBUPROFEN ORAL SUSPENSION — Original Application (PAI Holdings, LLC dba PAI Pharma)

See pricing